Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Clinical trial NCT06574620 · RECRUITING

Trial details

NCT number: NCT06574620
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma Locally Advanced Pancreatic Ductal Adenocarcinoma

Start date: 2025-11-28
Primary completion: 2028-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.